Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Collaboration source : Ir.biolinerx.com save search
BioLineRx Announces Clinical Trial Collaboration with Washington University School of Medicine to Evaluate Motixafortide for CD34+ Hematopoietic Stem Cell Mobilization for Gene Therapies in Sickle Cell Disease
Published: 2023-03-06 (Crawled : 12:00) - ir.biolinerx.com
BLRX | $0.6411 3.17% 3.07% 310K
|
Health Technology
|
| O: 1.54%
H: 3.33%
C: -1.33%
cd34 disease collaboration trial
BioLineRx Announces Collaboration Agreement with GenFleet Therapeutics to Further Develop Motixafortide in Pancreatic Ductal Adenocarcinoma (PDAC)
Published: 2022-06-28 (Crawled : 11:00) - ir.biolinerx.com
BLRX | $0.6411 3.17% 3.07% 310K
|
Health Technology
|
| O: 4.58%
H: 0.0%
C: -5.11%
collaboration therapeutics agreement pancreatic
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | News | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | News | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.